Drug
divalproex sodium extended release
divalproex sodium extended release is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
33%
Ph phase_4
2
67%
Phase Distribution
0
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (33.3%)
Phase 42 (66.7%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_4
Study of Depakote ER for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder
NCT00181727
completedphase_2
Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms
NCT00202514
completedphase_4
Safety And Efficacy Study Of Depakote ER To Treat Pediatric Bipolar Disorder
NCT00199966
Clinical Trials (3)
Showing 3 of 3 trials
NCT00181727Phase 4
Study of Depakote ER for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder
NCT00202514Phase 2
Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms
NCT00199966Phase 4
Safety And Efficacy Study Of Depakote ER To Treat Pediatric Bipolar Disorder
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3